title: [Therapeutic strategies for RAGE-mediated diseases].
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamamoto
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000235:genetics; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology; D024243:HMGB1 Protein / Q000502:physiology; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D058990:Molecular Targeted Therapy; D016328:NF-kappa B; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D018384:Oxidative Stress; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000037:antagonists & inhibitors / Q000502:physiology*; D051192:Receptors, Pattern Recognition; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
chemical_list: D024243:HMGB1 Protein; D006495:Heparin, Low-Molecular-Weight; D016328:NF-kappa B; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D051192:Receptors, Pattern Recognition; D048049:Extracellular Signal-Regulated MAP Kinases